Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins
The DeNovix CellDrop™ Automated Cell Counter has been awarded the Gold Seal of Quality based on outstanding scientist reviews
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
For their prize, Dr. Lieberman and her team have chosen to receive the upcoming low volume model, the microPro 25
The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients
BotrytisAlert harnesses Mologic’s expert lateral flow technology to enable earlier disease intervention and prevent wide-spread crop failures
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
Rentschler Biopharma to provide cGMP manufacturing services for mRNA-based vaccine candidate, developed by BioNTech and Pfizer against SARS-CoV-2
Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases
Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions
Normally an insulator, diamond becomes a metallic conductor when subjected to large strain in a new theoretical model
The Royal Swedish Academy of Sciences awards Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing
Harvey J. Alter, Michael Houghton, and Charles M. Rice are joint winners of 2020 Nobel Prize for medicine
The supercomputer is designed to solve some of the world’s most pressing medical challenges
Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology
The collaboration will ensure GMP production of material for the Phase 1 clinical trial of Scancell’s DNA vaccine against SARS-CoV-2
A new system capable of automatically turning words into molecules on demand will open up the digitisation of chemistry, scientists say
